MeiraGTx Holdings PLC MGTX:NASDAQ

MeiraGTx Holdings (MGTX) on Thursday reported a full-year 2021 net loss of $1.80 per diluted share, widening from a loss of $1.54 per share in 2020.

Analysts polled by Capital IQ expected a loss of $2.09.

Related party license revenue increased to $37.7 million in the year ended Dec. 31 from $15.6 million in 2020.

Analysts surveyed by Capital IQ expected revenue of $18.2 million.

The clinical-stage gene therapy company said it had cash and cash equivalents of $137.7 million as of Dec. 31, with about $22.4 million of receivables due in the next 30 days.

MeiraGTx said it expects it has enough capital to fund operating expenses and capital expenditure through Q2 of 2023.

The company's shares weret 1.2% higher in recent premarket activity.

Price: 14.52, Change: +0.17, Percent Change: +1.18